Last reviewed · How we verify
NCT05278923
The Impact of Soiled Airway Management on CPR Quality
NA trial testing SALAD simulation device in Airway Aspiration in 54 participants. Completed in 11 March 2019.
11 March 2019
Quick facts
| Lead sponsor | Shin Kong Wu Ho-Su Memorial Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 54 |
| Start date | 1 July 2018 |
| Primary completion | 11 March 2019 |
| Estimated completion | 11 March 2019 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- SALAD simulation device
Conditions studied
- Airway Aspiration — all drugs for Airway Aspiration →
- Cardiopulmonary Arrest — all drugs for Cardiopulmonary Arrest →
Sponsor
Shin Kong Wu Ho-Su Memorial Hospital
Who can join
Eligibility, any sex, with Airway Aspiration or Cardiopulmonary Arrest. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Regurgitation is an adverse event common during cardiopulmonary resuscitation (CPR) and occurs in 20%-32% of patients experiencing out-of-hospital cardiac arrest (OHCA). It can impair ventilation, induce aspiration, and decrease survival to hospital discharge. Gastric fluid in the airway obscures the laryngeal view, thereby considerably decreasing the first-pass success of endotracheal intubation (ETI) by paramedics. A human cadaver study reported that ETI outperforms other airway management devices, such as the i-gel, laryngeal mask, and laryngeal tube, in preventing aspiration when regurgitation occurs during CPR. However, ETI is also associated with multiple and prolonged CPR pauses.Compared with the use of supraglottic airway (SGA) devices, ETI results in more hands-off time during CPR. Recent randomised clinical trials have revealed that airway management with an SGA device provides superior outcomes to those of ETI in patients with OHCA. However, ETI remains the preferred management strategy for an airway affected by regurgitation in patients with OHCA. Current guidelines focus on the quality of CPR because it is a key determinant of survival in patients with OHCA. However, evidence regarding the impact of regurgitation during ETI on CPR quality is limited. This manikin simulation study assessed CPR quality during ETI in airways with and without regurgitation.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Compromised cardiopulmonary resuscitation quality due to regurgitation during endotracheal intubation: a randomised crossover manikin simulation study.
Lin LW, DuCanto J, Hsu CY, Su YC, et al · · 2022 · cited 1× · PMID 35810275 · DOI 10.1186/s12873-022-00662-0
Verify or expand the search:
- PubMed search for NCT05278923
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Shin Kong Wu Ho-Su Memorial Hospital trials
Trials by the same sponsor.
- NCT07324005 — Efficacy of Combining Ultrasound-Guided Needle Release of Transverse Carpal Ligament and Median Nerve Dextrose Water Hyd · NA · not yet recruiting
- NCT07207356 — Ultrasound Guided Transcutaneous Pulsed Radiofrequency for Cervical Radiculopathy · NA · recruiting
- NCT07032051 — Continuous Passive Motion to Prevent Ankle Contracture and Muscle Atrophy in Ventilated Patients · NA · not yet recruiting
- NCT06935877 — Additional Effect of Steroid on Hyaluronic Acid in Subdeltoid Bursitis · Phase 4 · not yet recruiting
- NCT06702046 — The Efficacy of Transcutaneous Pulsed Radiofrequency Acupuncture for Knee Osteoarthritis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05278923 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shin Kong Wu Ho-Su Memorial Hospital
- Last refreshed: 5 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05278923.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing